Name: Global Gabapentin Enacarbil Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.9 (213 reviews)

Global Gabapentin Enacarbil Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

A complete construal on the Global Gabapentin Enacarbil Market can be obtained through the market details such as growth drivers, latest developments, business strategies, regional study, and future market status. The report also covers information including latest opportunities and challenges along with the historical and future trends. It focuses on the market dynamics that is constantly changing due to the technological advancements and socio-economic status.

Data provided by Extent Research. Source: https://www.extentresearch.com/gabapentin-enacarbil-market

COVID-19 Impact Analysis:

In this report, the pre- and post-COVID impact on the market growth and development is well depicted for better understanding of the Gabapentin Enacarbil Market based on the financial and industrial analysis. The COVID-19 pandemic has affected a number of market and Global Gabapentin Enacarbil Market is no exception. However, the dominating players of the Global Gabapentin Enacarbil Market are adamant to adopt new strategies and look for new funding resources to overcome the rising obstacles in the market growth.

Industrial Analysis:

Some of the key players operating in the Global Gabapentin Enacarbil Market include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike Pharma, . The industrial study provides information such as business strategies, manufacturing processes, company profiling, financial gains, and other industrial aspects.

Segmentation of the Global Gabapentin Enacarbil Market:

By Product type

Capsule, Tablet,

by Application

Post-Herpetic Neuralgia (PHN), Restless Legs Syndrome (RLS), Others,

Geographical Distribution:

The regional study sheds light on the market economic status, supply and demand ration, social environment, and regional benefits. The regional market attractiveness offers a complete understanding of the Global Gabapentin Enacarbil Market even on the regional platform.

Dominating Regions:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

This report provides a clear elucidation of the Gabapentin Enacarbil Market through the various aspects such as market drivers, economic fluctuations, opportunities & challenges, regional analysis, and competitive landscape.

Important Market Analysis:

Report covers key market drivers, achievements, threats, and strategies
Regional analysis helps focus on the economic status and market development on both the global and regional platform
Changing competitive landscape provides information considering supply & demand ratio, business strategies adopted by key players, and latest trends
Key market players and regions dominating or showing tremendous growth are also reported

Report Scope and Market Segmentation

ATTRIBUTES	Global Gabapentin Enacarbil Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Gabapentin Enacarbil Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Gabapentin Enacarbil Product Introduction
    1.2 Market by Type
        1.2.1 Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Capsule
        1.2.3 Tablet
    1.3 Market by Application
        1.3.1 Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Post-Herpetic Neuralgia (PHN)
        1.3.3 Restless Legs Syndrome (RLS)
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts 2017-2035
    2.2 Global Gabapentin Enacarbil Revenue Estimates and Forecasts 2017-2035
    2.3 Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Gabapentin Enacarbil Sales by Region
        2.4.1 Global Gabapentin Enacarbil Sales by Region (2017-2022)
        2.4.2 Global Sales Gabapentin Enacarbil by Region (2023-2035)
    2.5 Global Gabapentin Enacarbil Revenue by Region
        2.5.1 Global Gabapentin Enacarbil Revenue by Region (2017-2022)
        2.5.2 Global Gabapentin Enacarbil Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gabapentin Enacarbil Sales by Manufacturers
        3.1.1 Global Top Gabapentin Enacarbil Manufacturers by Sales (2017-2022)
        3.1.2 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin Enacarbil in 2021
    3.2 Global Gabapentin Enacarbil Revenue by Manufacturers
        3.2.1 Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Enacarbil Revenue in 2021
    3.3 Global Gabapentin Enacarbil Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gabapentin Enacarbil Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gabapentin Enacarbil Sales by Type
        4.1.1 Global Gabapentin Enacarbil Historical Sales by Type (2017-2022)
        4.1.2 Global Gabapentin Enacarbil Forecasted Sales by Type (2023-2035)
        4.1.3 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2035)
    4.2 Global Gabapentin Enacarbil Revenue by Type
        4.2.1 Global Gabapentin Enacarbil Historical Revenue by Type (2017-2022)
        4.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2035)
    4.3 Global Gabapentin Enacarbil Price by Type
        4.3.1 Global Gabapentin Enacarbil Price by Type (2017-2022)
        4.3.2 Global Gabapentin Enacarbil Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Gabapentin Enacarbil Sales by Application
        5.1.1 Global Gabapentin Enacarbil Historical Sales by Application (2017-2022)
        5.1.2 Global Gabapentin Enacarbil Forecasted Sales by Application (2023-2035)
        5.1.3 Global Gabapentin Enacarbil Sales Market Share by Application (2017-2035)
    5.2 Global Gabapentin Enacarbil Revenue by Application
        5.2.1 Global Gabapentin Enacarbil Historical Revenue by Application (2017-2022)
        5.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2035)
    5.3 Global Gabapentin Enacarbil Price by Application
        5.3.1 Global Gabapentin Enacarbil Price by Application (2017-2022)
        5.3.2 Global Gabapentin Enacarbil Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Gabapentin Enacarbil Market Size by Type
        6.1.1 North America Gabapentin Enacarbil Sales by Type (2017-2035)
        6.1.2 North America Gabapentin Enacarbil Revenue by Type (2017-2035)
    6.2 North America Gabapentin Enacarbil Market Size by Application
        6.2.1 North America Gabapentin Enacarbil Sales by Application (2017-2035)
        6.2.2 North America Gabapentin Enacarbil Revenue by Application (2017-2035)
    6.3 North America Gabapentin Enacarbil Market Size by Country
        6.3.1 North America Gabapentin Enacarbil Sales by Country (2017-2035)
        6.3.2 North America Gabapentin Enacarbil Revenue by Country (2017-2035)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Gabapentin Enacarbil Market Size by Type
        7.1.1 Europe Gabapentin Enacarbil Sales by Type (2017-2035)
        7.1.2 Europe Gabapentin Enacarbil Revenue by Type (2017-2035)
    7.2 Europe Gabapentin Enacarbil Market Size by Application
        7.2.1 Europe Gabapentin Enacarbil Sales by Application (2017-2035)
        7.2.2 Europe Gabapentin Enacarbil Revenue by Application (2017-2035)
    7.3 Europe Gabapentin Enacarbil Market Size by Country
        7.3.1 Europe Gabapentin Enacarbil Sales by Country (2017-2035)
        7.3.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gabapentin Enacarbil Market Size by Type
        8.1.1 Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2035)
        8.1.2 Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2035)
    8.2 Asia Pacific Gabapentin Enacarbil Market Size by Application
        8.2.1 Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2035)
        8.2.2 Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2035)
    8.3 Asia Pacific Gabapentin Enacarbil Market Size by Region
        8.3.1 Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2035)
        8.3.2 Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Gabapentin Enacarbil Market Size by Type
        9.1.1 Latin America Gabapentin Enacarbil Sales by Type (2017-2035)
        9.1.2 Latin America Gabapentin Enacarbil Revenue by Type (2017-2035)
    9.2 Latin America Gabapentin Enacarbil Market Size by Application
        9.2.1 Latin America Gabapentin Enacarbil Sales by Application (2017-2035)
        9.2.2 Latin America Gabapentin Enacarbil Revenue by Application (2017-2035)
    9.3 Latin America Gabapentin Enacarbil Market Size by Country
        9.3.1 Latin America Gabapentin Enacarbil Sales by Country (2017-2035)
        9.3.2 Latin America Gabapentin Enacarbil Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gabapentin Enacarbil Market Size by Type
        10.1.1 Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2035)
    10.2 Middle East and Africa Gabapentin Enacarbil Market Size by Application
        10.2.1 Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2035)
    10.3 Middle East and Africa Gabapentin Enacarbil Market Size by Country
        10.3.1 Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Arbor Pharma
        11.1.1 Arbor Pharma Corporation Information
        11.1.2 Arbor Pharma Overview
        11.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Arbor Pharma Recent Developments
    11.2 Astellas
        11.2.1 Astellas Corporation Information
        11.2.2 Astellas Overview
        11.2.3 Astellas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Astellas Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Corporation Information
        11.3.2 GlaxoSmithKline Overview
        11.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Glenmark Pharma
        11.4.1 Glenmark Pharma Corporation Information
        11.4.2 Glenmark Pharma Overview
        11.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Glenmark Pharma Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Overview
        11.5.3 Pfizer Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pfizer Recent Developments
    11.6 Depomed
        11.6.1 Depomed Corporation Information
        11.6.2 Depomed Overview
        11.6.3 Depomed Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Depomed Recent Developments
    11.7 Teva
        11.7.1 Teva Corporation Information
        11.7.2 Teva Overview
        11.7.3 Teva Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Teva Recent Developments
    11.8 Mylan
        11.8.1 Mylan Corporation Information
        11.8.2 Mylan Overview
        11.8.3 Mylan Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Mylan Recent Developments
    11.9 Novartis
        11.9.1 Novartis Corporation Information
        11.9.2 Novartis Overview
        11.9.3 Novartis Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novartis Recent Developments
    11.10 Apotex
        11.10.1 Apotex Corporation Information
        11.10.2 Apotex Overview
        11.10.3 Apotex Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Apotex Recent Developments
    11.11 Sun Pharmaceutical
        11.11.1 Sun Pharmaceutical Corporation Information
        11.11.2 Sun Pharmaceutical Overview
        11.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Sun Pharmaceutical Recent Developments
    11.12 Aurobindo Pharma
        11.12.1 Aurobindo Pharma Corporation Information
        11.12.2 Aurobindo Pharma Overview
        11.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Aurobindo Pharma Recent Developments
    11.13 Intas
        11.13.1 Intas Corporation Information
        11.13.2 Intas Overview
        11.13.3 Intas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Intas Recent Developments
    11.14 Amneal
        11.14.1 Amneal Corporation Information
        11.14.2 Amneal Overview
        11.14.3 Amneal Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Amneal Recent Developments
    11.15 Marksans Pharma
        11.15.1 Marksans Pharma Corporation Information
        11.15.2 Marksans Pharma Overview
        11.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Marksans Pharma Recent Developments
    11.16 Alkem
        11.16.1 Alkem Corporation Information
        11.16.2 Alkem Overview
        11.16.3 Alkem Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Alkem Recent Developments
    11.17 Jiangsu Enhua
        11.17.1 Jiangsu Enhua Corporation Information
        11.17.2 Jiangsu Enhua Overview
        11.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Jiangsu Enhua Recent Developments
    11.18 Jiangsu Hengrui
        11.18.1 Jiangsu Hengrui Corporation Information
        11.18.2 Jiangsu Hengrui Overview
        11.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Jiangsu Hengrui Recent Developments
    11.19 Sailike Pharma
        11.19.1 Sailike Pharma Corporation Information
        11.19.2 Sailike Pharma Overview
        11.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Sailike Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gabapentin Enacarbil Industry Chain Analysis
    12.2 Gabapentin Enacarbil Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gabapentin Enacarbil Production Mode & Process
    12.4 Gabapentin Enacarbil Sales and Marketing
        12.4.1 Gabapentin Enacarbil Sales Channels
        12.4.2 Gabapentin Enacarbil Distributors
    12.5 Gabapentin Enacarbil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gabapentin Enacarbil Industry Trends
    13.2 Gabapentin Enacarbil Market Drivers
    13.3 Gabapentin Enacarbil Market Challenges
    13.4 Gabapentin Enacarbil Market Restraints
14 Key Findings in The Global Gabapentin Enacarbil Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Gabapentin Enacarbil Market